Inactivation of PI3K/Akt signaling mediates proliferation inhibition and G2/M phase arrest induced by andrographolide in human glioblastoma cells

作者: Yanchun Li , Pengfei Zhang , Feng Qiu , Lixia Chen , Caixia Miao

DOI: 10.1016/J.LFS.2012.04.044

关键词:

摘要: Abstract Aims Andrographolide, a principal diterpenoid lactone isolated from the traditional herbal medicine Andrographis paniculata , has been reported to show anti-tumor activity. Since high lipid solubility of andrographolide permits it penetrate blood–brain barrier and concentrate in brain, we hypothesized that may be potential chemotherapeutic agent for treatment glioblastomas. To clarify this point, investigated growth inhibitory effect mechanisms actions on human glioblastoma U251 U87 cells. Main methods MTT assay trypan blue exclusion were used investigate proliferation cytotoxic effects andrographolide, respectively. Cell cycle distribution was analyzed using flow cytometry. Apoptosis analysis proceeded by detecting cleavage caspase-3. The levels proteins probed Western blotting. Key findings results showed non-toxic concentrations inhibited cells through induction G2/M arrest, which accompanied down-regulating Cdk1 Cdc25C proteins. Additionally, decreased activity PI3K/Akt signaling, as demonstrated down-regulation expression phos-PI3K, phos-Akt, phos-mTOR phos-p70s6k Furthermore, additive inhibition, arrest phase-related observed, when combined with PI3K inhibitor LY294002 Significance We prove inhibits via inducing is mediated inhibiting signaling.

参考文章(30)
Yardena Nordenberg, Alexander Gorshtein, Michal Praiss, Efrat Kendler, Rafael Feinmesser, Ashley B. Grossman, Ilan Shimon, Simona Grozinsky-Glasberg, Hadara Rubinfeld, The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells Molecular and Cellular Endocrinology. ,vol. 315, pp. 87- 94 ,(2010) , 10.1016/J.MCE.2009.09.027
Christina Karlsson-Rosenthal, Jonathan B.A. Millar, Cdc25: mechanisms of checkpoint inhibition and recovery Trends in Cell Biology. ,vol. 16, pp. 285- 292 ,(2006) , 10.1016/J.TCB.2006.04.002
Deborah A Altomare, Joseph R Testa, Perturbations of the AKT signaling pathway in human cancer Oncogene. ,vol. 24, pp. 7455- 7464 ,(2005) , 10.1038/SJ.ONC.1209085
Sriram Rajagopal, R. Ajaya Kumar, Dhanvanthri S. Deevi, Chitkala Satyanarayana, R. Rajagopalan, Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. Journal of Experimental Therapeutics and Oncology. ,vol. 3, pp. 147- 158 ,(2003) , 10.1046/J.1359-4117.2003.01090.X
Marie-Odile Contour-Galcera, Alban Sidhu, Grégoire Prévost, Dennis Bigg, Bernard Ducommun, What's new on CDC25 phosphatase inhibitors. Pharmacology & Therapeutics. ,vol. 115, pp. 1- 12 ,(2007) , 10.1016/J.PHARMTHERA.2007.03.009
Severine I. Gharbi, Marketa J. Zvelebil, Stephen J. Shuttleworth, Tim Hancox, Nahid Saghir, John F. Timms, Michael D. Waterfield, Exploring the specificity of the PI3K family inhibitor LY294002. Biochemical Journal. ,vol. 404, pp. 15- 21 ,(2007) , 10.1042/BJ20061489
Leopold Arko, Igor Katsyv, Grace E. Park, William Patrick Luan, John K. Park, Experimental approaches for the treatment of malignant gliomas. Pharmacology & Therapeutics. ,vol. 128, pp. 1- 36 ,(2010) , 10.1016/J.PHARMTHERA.2010.04.015
Li-Xia Chen, Feng Qiu, Hong Wei, Ge-Xia Qu, Xin-Sheng Yao, Nine New ent‐Labdane Diterpenoids from the Aerial Parts of Andrographis paniculata Helvetica Chimica Acta. ,vol. 89, pp. 2654- 2664 ,(2006) , 10.1002/HLCA.200690237
A S Hamzah, N H Lajis, M F G Stevens, J Stanslas, S R Jada, C Matthews, M S Saad, Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G1 arrest and apoptosis British Journal of Pharmacology. ,vol. 155, pp. 641- 654 ,(2009) , 10.1038/BJP.2008.368